This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkler, K. Articles by März, W. Search for Related Content PubMed PubMed Citation Articles by Winkler, K. Articles by März, W.

Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia

Departments of Clinical Chemistry (K.W., M.M.H., I.F., H.W.), Obstetrics and Gynecology (B.W., M.K., H.-P.Z.), and Sports Medicine (M.W.B.), University of Freiburg, Germany; and Clinical Institute of Medical and Chemical Laboratory Diagnostics (W.M.), University of Graz, Graz, Austria

Address all correspondence and requests for reprints to: Karl Winkler, M.D., Department of Clinical Chemistry, School of Medicine, Albert Ludwigs-University, Hugstetter Strasse 55, D-79106 Freiburg, Germany. E-mail: kwinkler{at}ukl.uni-freiburg.de.

Disorders of the lipoprotein metabolism are a major cause of endothelial dysfunction that may result in hypertension and proteinuria, clinical hallmarks of preeclampsia (PE). Lipoproteins and low-density lipoprotein (LDL) subfractions were investigated in 15 women with severe PE and compared with 23 women with a normal course of pregnancy. Compared with normal pregnancy, in PE apolipoprotein (apo)B in very low-density lipoprotein was increased by 76% (P = 0.008), and the triglyceride content of intermediate dense lipoproteins (IDL) was increased by 51% (P < 0.001); cholesterol and apoB in LDL were decreased by 26% (P = 0.005) and 23% (P = 0.016), respectively. Although not significant, the LDL profile was dominated by the most buoyant LDL-1. ApoB in the most dense LDL (dLDL), namely LDL-5 and LDL-6, was significantly decreased by 49% (P < 0.001) and 55% (P < 0.001), respectively. Diastolic blood pressure was positively correlated with the triglyceride content of IDL (r = 6.31; P < 0.001 and r = 0.352; P = 0.033 by partial correlation controlling for the presence or absence of PE) and negatively correlated with the concentration of apoB in dLDL (r = -0.500; P = 0.002). In addition, IDL triglycerides correlated negatively with infant birth weight percentile (r = -0.373; P = 0.027) and positively with proteinuria (r = 0.430; P = 0.014). Low birth weight was associated with high IDL triglycerides and low rather than high concentrations of dLDL. Triglyceride-rich remnants are known to cause endothelial dysfunction. Because the triglyceride content of IDL was positively correlated with elevated blood pressure and proteinuria, triglyceride-rich remnant lipoproteins might contribute to the pathophysiology of PE.

Abbreviations: apo, Apolipoprotein; CH, cholesterol; CS, cesarean section; dLDL, dense low-density lipoprotein; HDL, high-density lipoprotein; HL, hepatic lipase; IDL, intermediate dense lipoprotein; LDL, low-density lipoprotein; LPL, lipoprotein lipase; PE, preeclampsia; TG, triglyceride; VLDL, very low-density lipoprotein.

This article has been cited by other articles:

				Joong Shin Park, K.-J. Oh, E. R. Norwitz, J.-S. Han, H.-J. Choi, Hyo Suk Seong, Yoon Dan Kang, C.-W. Park, Byoung Jae Kim, Jong Kwan Jun, et al. Identification of Proteomic Biomarkers of Preeclampsia in Amniotic Fluid Using SELDI-TOF Mass Spectrometry Reproductive Sciences, May 1, 2008; 15(5): 457 - 468. [Abstract] [PDF]

				A. T. Merchant, G. Msamanga, E. Villamor, E. Saathoff, M. O'Brien, E. Hertzmark, D. J. Hunter, and W. W. Fawzi Multivitamin Supplementation of HIV-Positive Women during Pregnancy Reduces Hypertension J. Nutr., July 1, 2005; 135(7): 1776 - 1781. [Abstract] [Full Text] [PDF]

				A. Brea, D. Mosquera, E. Martin, A. Arizti, J. L. Cordero, and E. Ros Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case-Control Study Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 1045 - 1050. [Abstract] [Full Text] [PDF]

				K. Winkler, C. Abletshauser, I. Friedrich, M. M. Hoffmann, H. Wieland, and W. Marz Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1153 - 1159. [Abstract] [Full Text] [PDF]

				K. Winkler, T. Konrad, S. Fullert, I. Friedrich, R. Destani, M. W. Baumstark, K. Krebs, H. Wieland, and W. Marz Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension: A double-blind, placebo-controlled study Diabetes Care, September 1, 2003; 26(9): 2588 - 2594. [Abstract] [Full Text] [PDF]